The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Kendle names Cutler new CEO in succession plan

February 14, 2011 12:45 pm | by The Associated Press | News | Comments

Clinical research company Kendle International Inc. said Monday it named Stephen Cutler president and CEO to replace Dr. Candace Kendle.Cutler, 51, is currently a senior vice president and chief operating officer. Kendle, 64 and a co-founder of Kendle, will continue to serve as chairman of the...

FDA Finalizes Regulation for Certain Software, Hardware Used With Medical Devices

February 14, 2011 10:30 am | by U.S. Food & Drug Administration | News | Comments

Today, the FDA announced a final rule that provides a less-burdensome path to market for certain hardware and software products used with medical devices. The rule classifies these products, known as Medical Device Data Systems or MDDS, as Class I or...


Health Dialog names Bill Pelzar as new CIO

February 14, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Boston's Health Dialog Services Corp. has hired Bill Pelzar, former Gartner Inc. executive, as the company's chief information officer.


FDA: Data gatherers won't need same OK as med devices

February 14, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Saying that is providing a “less-burdensome path to market” for low-risk products used with medical devices, the U.S. Food and Drug Administration today set new rules for what it calls Medical Device Data Systems (MDDS) or Class I systems that perform tasks such as storing data collected...

New Anti-Clotting Drug Added to Recommendations for Treating Irregular Heartbeat

February 14, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

DALLAS, Feb. 14, 2011 /PRNewswire-USNewswire/ -- The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association...


ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination

February 14, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Feb. 14, 2011 /- Zoledronic acid (sold by Novartis as Zometa, Aclasta, and Reclast) is used to treat Osteoporosis, Tumor Metastasis, and Paget's Disease with sales of $2 billion a year.(1)  It is associated with side effects such as post-dose syndrome and osteonecrosis of...


Military/civilian medical experts turning attention to 'army' of injured civilians supporting wars

February 14, 2011 9:35 am | by EurekAlert | News | Comments

(Johns Hopkins Medical Institutions) After analyzing data on 2,155 private contractors, diplomats and other civilians supporting war efforts in Iraq and Afghanistan who were medically evacuated out of combat zones, researchers have found they are more likely to be evacuated for...


Medical Devices and Diagnostics Analyst Joins MLV to Further Expand its Coverage of the Life Sciences Sector

February 14, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 14, 2011 /- McNicoll, Lewis & Vlak LLC (MLV), a boutique investment bank focused on capital intensive industries, announced today that Caroline Corner, Ph. D. has joined the firm as a Managing Director in Research where she will cover the Medical Devices and Diagnostics...


Summary Box: Emergency Medical Services Sale

February 14, 2011 8:45 am | by The Associated Press | News | Comments

THE DEAL: Emergency Medical Services Corp., which transports patients to hospitals and runs a physician outsourcing business, agreed Monday to sell itself to private equity firm Clayton, Dubilier & Rice for $64 per share, or about $3.2 billion.ANTICIPATION: The Greenwood Village, Colo., company...

Onex Corp. sells stake in Emergency Medical Services

February 14, 2011 7:45 am | by The Associated Press | News | Comments

Investment firm Onex Corp. (TSX:OCX) agrees to sell its stake in Emergency Medical Services Corp. (NYSE:EMS) for US$878 million.

ASU, Mayo Clinic enhance collaboration with formal commitment

February 14, 2011 7:34 am | by Arizona State University | News | Comments

ASU and Mayo Clinic have signed an agreement to broaden and deepen their collaboration in health care, medical research and more


Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease

February 14, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

PORTLAND, Ore., Feb. 14, 2011 /- A commonly prescribed osteoporosis drug is associated with a slightly elevated risk of developing the rare, but serious condition, osteonecrosis of the jaw; nonetheless the risk remains extremely low.  These findings are published online in the...


Dynatronics Announces Fiscal Second Quarter Results

February 14, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Feb. 14, 2011 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced results for its fiscal second quarter ended December 31, 2010. Sales for the quarter ended December 31, 2010, were $8,199,347, compared to $8,501,437 for the quarter ended December 31, 2009. Sales for...


Bluetooth Low Energy Solution Offers Device Connectivity

February 14, 2011 6:51 am | Product Releases | Comments

Texas Instruments Inc. has introduced two ultra-low power, short-range wireless connectivity solutions for consumer medical, mobile accessories, and sports and wellness applications.

Resins Aid With Ever-Toughening Requirements for New Medical Equipment

February 14, 2011 6:41 am | Product Releases | Comments

At MD&M West 2011, SABIC Innovative Plastics announced that GE Healthcare, a global leader in medical technology, has selected Valox resin for the housing and Xylex resin...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.